FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211051630> ?p ?o ?g. }

• W4211051630 endingPage "1396" @default.
• W4211051630 startingPage "1384" @default.
• W4211051630 abstract "The genesis of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is driven by oncogenic co-operation among immunological stimulations and acquired genetic changes. We previously identified recurrent CCR6 mutations in MALT lymphoma, with majority predicted to result in truncated proteins lacking the phosphorylation motif important for receptor desensitization. Functional consequences of these mutational changes, the molecular mechanisms of CCR6 activation and how this receptor signaling contributes to MALT lymphoma development remain to be investigated. In the present study, we demonstrated that these mutations impaired CCR6 receptor internalization and were activating changes, being more potent in apoptosis resistance, malignant transformation, migration and intracellular signaling, particularly in the presence of the ligands CCL20, HBD2 (human b defensin 2) and HD5 (human a defensin 5). CCR6 was highly expressed in malignant B cells irrespective of the lymphoma sites. HBD2 and CCL20 were constitutively expressed by the duct epithelial cells of salivary glands, and also those involved in lymphoepithelial lesions (LEL) in salivary gland MALT lymphoma. While in the gastric setting, HBD2, and HD5, to a less extent CCL20, were highly expressed in epithelial cells of pyloric and intestinal metaplasia respectively including those involved in LEL, which are adaptive responses to chronic Helicobacter pylori infection. These findings suggest that CCR6 signaling is most likely active in MALT lymphoma, independent of its mutation status. The observations explain why the emergence of malignant B cells and their clonal expansion in MALT lymphoma are typically around LEL, linking the innate immune responses to lymphoma genesis." @default.
• W4211051630 created "2022-02-13" @default.
• W4211051630 creator A5002852999 @default.
• W4211051630 creator A5048018897 @default.
• W4211051630 creator A5051974926 @default.
• W4211051630 creator A5058842093 @default.
• W4211051630 creator A5082659522 @default.
• W4211051630 date "2022-02-10" @default.
• W4211051630 modified "2023-10-17" @default.
• W4211051630 title "CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma development" @default.
• W4211051630 cites W1968797324 @default.
• W4211051630 cites W1982535426 @default.
• W4211051630 cites W1984621574 @default.
• W4211051630 cites W1989969172 @default.
• W4211051630 cites W1993167116 @default.
• W4211051630 cites W1993887960 @default.
• W4211051630 cites W1997929840 @default.
• W4211051630 cites W2001880241 @default.
• W4211051630 cites W2010459522 @default.
• W4211051630 cites W2010479391 @default.
• W4211051630 cites W2021612022 @default.
• W4211051630 cites W2025637665 @default.
• W4211051630 cites W2040338425 @default.
• W4211051630 cites W2045205786 @default.
• W4211051630 cites W2050741018 @default.
• W4211051630 cites W2055987809 @default.
• W4211051630 cites W2065116529 @default.
• W4211051630 cites W2065138362 @default.
• W4211051630 cites W2081513812 @default.
• W4211051630 cites W2083925854 @default.
• W4211051630 cites W2091629951 @default.
• W4211051630 cites W2096730265 @default.
• W4211051630 cites W2115511122 @default.
• W4211051630 cites W2147436067 @default.
• W4211051630 cites W2148959597 @default.
• W4211051630 cites W2156082292 @default.
• W4211051630 cites W2430842590 @default.
• W4211051630 cites W2497003890 @default.
• W4211051630 cites W2594913815 @default.
• W4211051630 cites W2728882014 @default.
• W4211051630 cites W2791977325 @default.
• W4211051630 cites W2793041345 @default.
• W4211051630 cites W2799560790 @default.
• W4211051630 cites W2802426702 @default.
• W4211051630 cites W2912783011 @default.
• W4211051630 cites W2912951723 @default.
• W4211051630 cites W2946888689 @default.
• W4211051630 cites W2948545594 @default.
• W4211051630 cites W2974572712 @default.
• W4211051630 cites W3014973223 @default.
• W4211051630 cites W301540668 @default.
• W4211051630 cites W3035444582 @default.
• W4211051630 cites W3036759197 @default.
• W4211051630 cites W3163256611 @default.
• W4211051630 cites W3165426195 @default.
• W4211051630 doi "https://doi.org/10.3324/haematol.2021.280067" @default.
• W4211051630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35142152" @default.
• W4211051630 hasPublicationYear "2022" @default.
• W4211051630 type Work @default.
• W4211051630 citedByCount "2" @default.
• W4211051630 countsByYear W42110516302023 @default.
• W4211051630 crossrefType "journal-article" @default.
• W4211051630 hasAuthorship W4211051630A5002852999 @default.
• W4211051630 hasAuthorship W4211051630A5048018897 @default.
• W4211051630 hasAuthorship W4211051630A5051974926 @default.
• W4211051630 hasAuthorship W4211051630A5058842093 @default.
• W4211051630 hasAuthorship W4211051630A5082659522 @default.
• W4211051630 hasBestOaLocation W42110516301 @default.
• W4211051630 hasConcept C107006841 @default.
• W4211051630 hasConcept C12823836 @default.
• W4211051630 hasConcept C13373296 @default.
• W4211051630 hasConcept C203014093 @default.
• W4211051630 hasConcept C2779338263 @default.
• W4211051630 hasConcept C2779526237 @default.
• W4211051630 hasConcept C502942594 @default.
• W4211051630 hasConcept C83360876 @default.
• W4211051630 hasConcept C86803240 @default.
• W4211051630 hasConcept C8891405 @default.
• W4211051630 hasConcept C94205230 @default.
• W4211051630 hasConceptScore W4211051630C107006841 @default.
• W4211051630 hasConceptScore W4211051630C12823836 @default.
• W4211051630 hasConceptScore W4211051630C13373296 @default.
• W4211051630 hasConceptScore W4211051630C203014093 @default.
• W4211051630 hasConceptScore W4211051630C2779338263 @default.
• W4211051630 hasConceptScore W4211051630C2779526237 @default.
• W4211051630 hasConceptScore W4211051630C502942594 @default.
• W4211051630 hasConceptScore W4211051630C83360876 @default.
• W4211051630 hasConceptScore W4211051630C86803240 @default.
• W4211051630 hasConceptScore W4211051630C8891405 @default.
• W4211051630 hasConceptScore W4211051630C94205230 @default.
• W4211051630 hasIssue "6" @default.
• W4211051630 hasLocation W42110516301 @default.
• W4211051630 hasLocation W42110516302 @default.
• W4211051630 hasLocation W42110516303 @default.
• W4211051630 hasOpenAccess W4211051630 @default.
• W4211051630 hasPrimaryLocation W42110516301 @default.
• W4211051630 hasRelatedWork W1555550984 @default.
• W4211051630 hasRelatedWork W2032563203 @default.

• next